INSIGHTS ON CLINICAL TRIAL DESIGN
-
How To Reduce Eligibility Risk And Prevent Protocol Deviations
Eliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
-
Why Should Site Agility Be Your Next Competitive Advantage?
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.
-
Precision Medicine In Pediatrics: Biomarkers and Assay Development
Discover the rise in FDA-approved pediatric therapies and the role of precision medicine in tailoring treatments to genetic profiles, as well as how biomarkers and assays can enhance pediatric care.
-
3 Essential Components Of Successful Renal And Hepatic Impairment Studies
Kidney and liver function affect how drugs work in the body. Learn how impairment studies help set safe, effective dosing for these patients.
-
How Modern RTSM Platforms Are Eliminating Delays2/25/2026
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
-
Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors12/4/2025
Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.
-
The Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials11/21/2025
Explore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.
-
Human-Centered RTSM Design Enhances Data, Safety, And Operations12/5/2025
Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.
-
Why Are Sponsors Prioritizing Ophthalmology Clinical Trials?3/18/2026
Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Discover Scout's strategies for elevated, eco-friendly face-to-face and hybrid events. ecoScout for Meetings takes a comprehensive approach to minimizing carbon emissions and maintaining the highest standards of quality and service.
-
Looking to better understand how to solve your organization’s specific clinical trial challenges? In 3 minutes, receive a personalized assessment, with customized results based on a specific role, which will provide a solution-based report curated to your priorities and requirements.
-
Expert Support for Clinical Research and Research Administration
-
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.